Diagnosis of bacteraemia and growth times

International Journal of Infectious Diseases

Volumn 41, Issue , 2015, Pages 6-10

  Ruiz Giardín, Jose Manuel ^a   Martin Díaz, Rosa M ^a   Jaqueti Aroca, Jerónimo ^a   Garcia Arata, Isabel ^a   San Martín López, Juan Víctor ^a   Sáiz Sánchez Buitrago, Miguel ^b  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Bacteriemias; Blood cultures; Diagnosis; Growth time

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL GROWTH TIME; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTEROIDES; BLOOD CULTURE; CANDIDA; CELL CULTURE EQUIPMENT; CLOSTRIDIUM; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORYNEBACTERIUM; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; ENTEROBACTERIACEAE; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; HUMAN; LISTERIA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NONHUMAN; PREDICTIVE VALUE; PROPIONIBACTERIUM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TIME; TREATMENT OUTCOME; ADULT; AGED; AREA UNDER THE CURVE; FEMALE; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; TIME FACTOR;

ADULT; AGED; AREA UNDER CURVE; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84946562197     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.10.008     Document Type: Article

References (22)

1. Baron E.J., Weinstein M.P., Dunne W.M., Yagupsky P., Welch D.F., Wilson D.M. Cumitech 1C, blood cultivate IV 2005, ASM Press, Washington, DC.
2. Principles and procedures for blood cultures. Approved guideline. CLSI document M47-A 2007, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA.
3. Cockerill F.R., Wilson J.W., Vetter E.A., Goodman K.M., Torgerson C.A., Harmsen W.S., et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004, 38:24-30.
4. Richter S.S., Beekmann S.E., Croco J.L., Diekema D.J., Koontz F.P., Pfaller M.A., Doern G.V. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol 2002, 40:2437.
5. Gómez J., García-Vázquez E., Baños R., Canteras M., Ruiz J., Baños V., et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 2007, 26:239-245.
6. Lombardi D.P., Engleberg C. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 1992, 92:53-60.
7. Arpi M., Renneberg J., Andersen H.K., Nielsen B., Larsen S.O. Bacteremia at a Danish university hospital during a twenty five-year period (1968-1992). Scand J Infect Dis 1995, 27:245-251.
8. Rogers M.S., Oppenheim B.A. The use of continuous monitoring blood culture systems in the diagnosis of catheter related sepsis. J Clin Pathol 1998, 51:635-637.
9. Marra A.R., Edmond M.B., Forbes B.A., Wenzel R.P., Bearman G.M. Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol 2006, 44:1342-1346.
10. Martinez J.A., Pozo L., Almela M., Marco F., Soriano A., Lopez F., et al. Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 2007, 13:709-716.
11. Khatib R., Riederer K., Saeed S., Johnson L.B., Fakih M.G., Sharma M., et al. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 2005, 41:594-598.
12. Weinstein M.P., Reller L.B., Murphy J.R., Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983, 5:35-53.
13. Ilstrup D.M., Washington J.A. The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis 1983, 1:107-110.
14. Clancy C.J., Nguyen M.H. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013, 56:1284-1292.
15. Guery B.P., Arendrup M.C., Auzinger G., Azoulay E., Borges S M., Johnson E.M., et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis. Intensive Care Med 2009, 35:55-62.
16. Falagas M.E., Apostolou K.E., Pappas V.D. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006, 25:419-425.
17. Michalopoulos A.S., Geroulanos S., Mentzelopoulos S.D. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003, 124:2244-2255.
18. Paphitou N.I., Ostrosky-Zeichner L., Rex J.H. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005, 43:235-243.
19. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26:271-276.
20. Shorr A.F., Sun X., Johannes R.S., Yaitanes A., Tabak Y.P. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest 2011, 140:1177-1183.
21. León C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. EPCAN Study Group, A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737.
22. Leroy G., Lambiotte F., Thévenin D., Lemaire C., Parmentier E., Devos P., Leroy O. Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care 2011, 1:50.